
ANZUP 2019 Interviews - Dr Alison Birtle & Prof Ian Davis discuss the phase 3 POUT trial
Dr Alison Birtle & Prof Ian Davis discuss the development and execution of the phase 3 POUT trial which has set the new standard of the benefit of adjuvant chemotherapy in men with locally advanced up...
16 Syys 20196min

Ep. 2 Prof Francesco Montorsi - Penile rehabilitation post radical prostatectomy
Prof Francesco Montorsi talks with Joseph Ischia & Nathan Lawrentshuk about the long and short of penile rehabilitation.
28 Elo 201921min

Series 2 Ep. 1 Dr John Yaxley – Open v Robot Radical Prostatectomy
Talking Urology Series 2 Episode 1 – Join Joseph and Nathan as they talk with John Yaxley and discuss if robotic surgery achieves better outcomes than open surgery when it comes to radical prostatecto...
20 Heinä 201915min

USANZ 2019 Conference Summary
Talking Urology conducted a series of live recordings at USANZ 2019 conference in Brisbane. Joseph Ischia discusses a range of topics with the following distinguished luminaries in the field of urolo...
27 Kesä 201933min

SYG Alpha blocker - So You’re Gonna… start an alpha-blocker with Claus Roehrborn 05272
A/Professor Joseph Ischia and co-host Dr Rachel Esler talk with Prof Claus Roehrborn about the key literature and take home points for starting BPH patients on alpha-blocker therapy.
2 Kesä 201930min

ANZUP 2018 Interviews - Laurence Albiges & Monty Pal discuss the CARMENA trial (Interview 2)
A/Prof Andrew Weickhardt discusses the CARMENA trial with A/Prof Laurence Albiges and Dr Monty Pal. Can we take away any positives from this negative trial?
2 Marras 20184min

ANZUP 2018 Interviews - Laurence Albiges & Monty Pal discuss biomarkers in metastatic RCC
A/Prof Laurence Albiges and Dr Monty Pal discuss the changing landscape and biomarkers in metastatic renal cell carcinoma with A/Prof Andrew Weickhardt.
2 Marras 201812min

ANZUP 2018 Interviews - Angie Smith explores the management of BCG refractory NMIBC
Assistant Prof Angie Smith discusses the four types of BCG failure and subsequent management in patients with non-muscle invasive bladder cancer.
2 Marras 20187min



















